Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents

Abstract Background The identification of biomarkers that predict susceptibility to major depressive disorder and treatment response to antidepressants is a major challenge. Vortioxetine is a novel multimodal antidepressant that possesses pro-cognitive properties and differentiates from other conven...

Full description

Bibliographic Details
Main Authors: Jessica A. Waller, Sara Holm Nygaard, Yan Li, Kristian Gaarn du Jardin, Joseph A. Tamm, Aicha Abdourahman, Betina Elfving, Alan L. Pehrson, Connie Sánchez, Rasmus Wernersson
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Neuroscience
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12868-017-0376-x
_version_ 1818537058959884288
author Jessica A. Waller
Sara Holm Nygaard
Yan Li
Kristian Gaarn du Jardin
Joseph A. Tamm
Aicha Abdourahman
Betina Elfving
Alan L. Pehrson
Connie Sánchez
Rasmus Wernersson
author_facet Jessica A. Waller
Sara Holm Nygaard
Yan Li
Kristian Gaarn du Jardin
Joseph A. Tamm
Aicha Abdourahman
Betina Elfving
Alan L. Pehrson
Connie Sánchez
Rasmus Wernersson
author_sort Jessica A. Waller
collection DOAJ
description Abstract Background The identification of biomarkers that predict susceptibility to major depressive disorder and treatment response to antidepressants is a major challenge. Vortioxetine is a novel multimodal antidepressant that possesses pro-cognitive properties and differentiates from other conventional antidepressants on various cognitive and plasticity measures. The aim of the present study was to identify biological systems rather than single biomarkers that may underlie vortioxetine’s treatment effects. Results We show that the biological systems regulated by vortioxetine are overlapping between mouse and rat in response to distinct treatment regimens and in different brain regions. Furthermore, analysis of complexes of physically-interacting proteins reveal that biomarkers involved in transcriptional regulation, neurodevelopment, neuroplasticity, and endocytosis are modulated by vortioxetine. A subsequent qPCR study examining the expression of targets in the protein–protein interactome space in response to chronic vortioxetine treatment over a range of doses provides further biological validation that vortioxetine engages neuroplasticity networks. Thus, the same biology is regulated in different species and sexes, different brain regions, and in response to distinct routes of administration and regimens. Conclusions A recurring theme, based on the present study as well as previous findings, is that networks related to synaptic plasticity, synaptic transmission, signal transduction, and neurodevelopment are modulated in response to vortioxetine treatment. Regulation of these signaling pathways by vortioxetine may underlie vortioxetine’s cognitive-enhancing properties.
first_indexed 2024-12-11T18:45:52Z
format Article
id doaj.art-6ad74c4aa9b34a46b8e8a08350e7b99c
institution Directory Open Access Journal
issn 1471-2202
language English
last_indexed 2024-12-11T18:45:52Z
publishDate 2017-08-01
publisher BMC
record_format Article
series BMC Neuroscience
spelling doaj.art-6ad74c4aa9b34a46b8e8a08350e7b99c2022-12-22T00:54:27ZengBMCBMC Neuroscience1471-22022017-08-0118111510.1186/s12868-017-0376-xNeuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodentsJessica A. Waller0Sara Holm Nygaard1Yan Li2Kristian Gaarn du Jardin3Joseph A. Tamm4Aicha Abdourahman5Betina Elfving6Alan L. Pehrson7Connie Sánchez8Rasmus Wernersson9External Sourcing and Scientific Excellence, Lundbeck Research U.S.A.Intomics A/SExternal Sourcing and Scientific Excellence, Lundbeck Research U.S.A.Translational Neuropsychiatry Unit, Aarhus UniversityIn Vitro Biology, Lundbeck Research U.S.A.In Vitro Biology, Lundbeck Research U.S.A.Translational Neuropsychiatry Unit, Aarhus UniversityExternal Sourcing and Scientific Excellence, Lundbeck Research U.S.A.External Sourcing and Scientific Excellence, Lundbeck Research U.S.A.Intomics A/SAbstract Background The identification of biomarkers that predict susceptibility to major depressive disorder and treatment response to antidepressants is a major challenge. Vortioxetine is a novel multimodal antidepressant that possesses pro-cognitive properties and differentiates from other conventional antidepressants on various cognitive and plasticity measures. The aim of the present study was to identify biological systems rather than single biomarkers that may underlie vortioxetine’s treatment effects. Results We show that the biological systems regulated by vortioxetine are overlapping between mouse and rat in response to distinct treatment regimens and in different brain regions. Furthermore, analysis of complexes of physically-interacting proteins reveal that biomarkers involved in transcriptional regulation, neurodevelopment, neuroplasticity, and endocytosis are modulated by vortioxetine. A subsequent qPCR study examining the expression of targets in the protein–protein interactome space in response to chronic vortioxetine treatment over a range of doses provides further biological validation that vortioxetine engages neuroplasticity networks. Thus, the same biology is regulated in different species and sexes, different brain regions, and in response to distinct routes of administration and regimens. Conclusions A recurring theme, based on the present study as well as previous findings, is that networks related to synaptic plasticity, synaptic transmission, signal transduction, and neurodevelopment are modulated in response to vortioxetine treatment. Regulation of these signaling pathways by vortioxetine may underlie vortioxetine’s cognitive-enhancing properties.http://link.springer.com/article/10.1186/s12868-017-0376-xAntidepressantMultimodalSynaptic plasticityNetwork biologyVortioxetine
spellingShingle Jessica A. Waller
Sara Holm Nygaard
Yan Li
Kristian Gaarn du Jardin
Joseph A. Tamm
Aicha Abdourahman
Betina Elfving
Alan L. Pehrson
Connie Sánchez
Rasmus Wernersson
Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
BMC Neuroscience
Antidepressant
Multimodal
Synaptic plasticity
Network biology
Vortioxetine
title Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
title_full Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
title_fullStr Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
title_full_unstemmed Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
title_short Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
title_sort neuroplasticity pathways and protein interaction networks are modulated by vortioxetine in rodents
topic Antidepressant
Multimodal
Synaptic plasticity
Network biology
Vortioxetine
url http://link.springer.com/article/10.1186/s12868-017-0376-x
work_keys_str_mv AT jessicaawaller neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT saraholmnygaard neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT yanli neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT kristiangaarndujardin neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT josephatamm neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT aichaabdourahman neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT betinaelfving neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT alanlpehrson neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT conniesanchez neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents
AT rasmuswernersson neuroplasticitypathwaysandproteininteractionnetworksaremodulatedbyvortioxetineinrodents